Left atrial and ventricular radiation doses associate with long-term cardiac events after breast radiotherapy

After 16.5 years, left atrial maximum dose was associated with major cardiac events, while left ventricular mean dose tracked with coronary disease.

KEY POINTS

  • This retrospective study included 878 women receiving adjuvant breast cancer radiotherapy at UZ Leuven in 2007–2008, with median follow-up of 16.5 years. All received three-dimensional conformal RT, generally 50 Gy in 25 fractions, with or without a tumor-bed boost; 173 patients developed major adverse cardiac events (MACE), of whom 167 were successfully matched to 167 controls.
  • Across the original 878-patient cohort, newly recorded cardiovascular diagnoses included atrial fibrillation in 98 patients (11.2%), heart failure in 82 (9.3%), coronary artery disease in 46 (5.2%), and valvular disease in 180 (20.5%). These outcomes were not mutually exclusive, and median time to MACE was 8.32 years after RT.
  • The investigators retrospectively delineated 18 cardiac substructures, including individual chambers, coronary arteries, valves, conduction nodes, and the heart base. Mean heart dose was 6.62 ± 5.20 Gy in MACE patients versus 5.76 ± 4.96 Gy in controls (p=0.0916), without a statistically significant association in this analysis.
  • In multivariable matched analysis, maximum left atrial dose was independently associated with MACE (OR 1.046 per Gy, 95% CI 1.025–1.067; p<0.0001). Mean left atrial maximum dose was 15.91 Gy in patients with MACE versus 9.37 Gy in controls, suggesting that exposure to specific cardiac regions may provide information beyond conventional mean heart dose.
  • Higher left atrial maximum dose was also associated with individual cardiovascular outcomes: heart failure (HR 1.037 per Gy; p<0.0001), atrial fibrillation (HR 1.019; p=0.0115), and valvular disease (HR 1.021; p=0.0034). Mean left atrial maximum doses were 17.81 versus 11.07 Gy for patients with versus without heart failure, and 15.12 versus 11.71 Gy for those with versus without atrial fibrillation.
  • Mean left ventricular dose independently correlated with subsequent coronary artery disease (HR 1.068 per Gy, 95% CI 1.008–1.131; p=0.0251). Patients developing coronary disease received a mean left ventricular dose of 5.51 Gy versus 3.81 Gy in those without this outcome, while left ventricular V10Gy and V15Gy were also associated with coronary events in univariable analyses.
  • Despite matching for several cardiovascular risk factors and systemic treatments, patients with MACE had more advanced cancer and a higher prevalence of previous cardiac disease. The study also reflects older 3D conformal techniques without routine DIBH, while some boost doses could not be reconstructed; correlated cardiac dose metrics and retrospective confounding prevent derivation of reliable causal thresholds.

CLINICAL TAKEAWAY

Long-term cardiovascular risk after breast radiotherapy may depend on radiation exposure to specific cardiac structures, particularly the left atrium and left ventricle, rather than mean heart dose alone. These findings support considering cardiac substructure sparing during plan evaluation, but they do not establish new dose constraints, and prospective validation with contemporary heart-sparing techniques is required.

SOURCE

Clinical and Translational Radiation Oncology

Browse more research Suggest a correction